Bone morphogenetic protein-6: Potential mediator of osteoblastic metastases in prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 4, 2000, Pages 283-285

  Thomas, B G ^a   Hamdy, F C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Bone morphogenetic protein 6; Osteoblastic skeletal metastases; Prostate carcinoma

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; ENDOTHELIN 1; FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE METASTASIS; CANCER CELL; CANCER SURVIVAL; CARCINOGENESIS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; RECURRENCE RISK;

EID: 0034507504     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500482     Document Type: Article

References (10)

1. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast like cells
2. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer
3. Cancer and bone
4. Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment
5. Bone formation by autoinduction
6. Human bone morphogenetic protein-15, a new member of the transforming growth factor beta superfamily
7. Expression of bone morphogenetic proteins in human prostatic adenocarcinomaand benign prostatie hyperplasia
8. Immunolocalisation and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue
9. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies
10. Prognostic value of bone morphogenetic protein-6 (BMP-6) expression in clinically organ confined prostate cancer